This document provides the first Chinese expert consensus to guide the standardized clinical application of coronary bioresorbable scaffolds.
Answers are grounded in this paper and cite their sources.
Standardizes BRS use in Chinese PCI; extends global consensus and informs future local trials.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
A 2020 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: